The site of breast cancer metastases dictates their clonal composition and reversible transcriptomic profile.
Journal
Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
received:
27
10
2020
accepted:
25
05
2021
entrez:
8
7
2021
pubmed:
9
7
2021
medline:
9
4
2022
Statut:
epublish
Résumé
Intratumoral heterogeneity is a driver of breast cancer progression, but the nature of the clonal interactive network involved in this process remains unclear. Here, we optimized the use of optical barcoding to visualize and characterize 31 cancer subclones in vivo. By mapping the clonal composition of thousands of metastases in two clinically relevant sites, the lungs and liver, we found that metastases were highly polyclonal in lungs but not in the liver. Furthermore, the transcriptome of the subclones varied according to their metastatic niche. We also identified a reversible niche-driven signature that was conserved in lung and liver metastases collected during patient autopsies. Among this signature, we found that the tumor necrosis factor-α pathway was up-regulated in lung compared to liver metastases, and inhibition of this pathway affected metastasis diversity. These results highlight that the cellular and molecular heterogeneity observed in metastases is largely dictated by the tumor microenvironment.
Identifiants
pubmed: 34233875
pii: 7/28/eabf4408
doi: 10.1126/sciadv.abf4408
pmc: PMC8262813
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).
Références
Bioinformatics. 2013 Jul 15;29(14):1840-1
pubmed: 23681123
Cell Rep. 2018 Nov 20;25(8):2208-2222.e7
pubmed: 30463016
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
Cell Death Differ. 2020 Oct;27(10):2768-2780
pubmed: 32341449
Nat Genet. 2020 Jul;52(7):701-708
pubmed: 32424352
Science. 2014 Jun 20;344(6190):1396-401
pubmed: 24925914
Nat Protoc. 2012 Apr 05;7(5):839-49
pubmed: 22481527
Mol Cancer Res. 2010 Oct;8(10):1319-27
pubmed: 20724460
J Clin Oncol. 2008 Mar 10;26(8):1275-81
pubmed: 18250347
Med Oncol. 2013 Mar;30(1):388
pubmed: 23292831
Cancers (Basel). 2019 Oct 16;11(10):
pubmed: 31623163
Nat Commun. 2014 Dec 23;5:5871
pubmed: 25532760
Mol Ther. 2017 Mar 1;25(3):621-633
pubmed: 28109958
Cell. 2014 Aug 28;158(5):1110-1122
pubmed: 25171411
Am J Clin Oncol. 1990 Aug;13(4):294-8
pubmed: 2198793
Cytokine Growth Factor Rev. 2015 Oct;26(5):489-98
pubmed: 26209885
Sci Rep. 2019 May 10;9(1):7202
pubmed: 31076648
Proc Natl Acad Sci U S A. 2019 Mar 26;116(13):6140-6145
pubmed: 30850544
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
NPJ Precis Oncol. 2018 Feb 16;2(1):4
pubmed: 29872722
Nature. 2014 Oct 2;514(7520):54-8
pubmed: 25079331
JCI Insight. 2018 Aug 23;3(16):
pubmed: 30135299
Cancer Res. 1976 Mar;36(3):889-94
pubmed: 1253177
Int J Biostat. 2018 Jul 7;14(2):
pubmed: 29981281
Cell. 2007 Nov 16;131(4):669-81
pubmed: 18022362
Nat Commun. 2018 Nov 29;9(1):5079
pubmed: 30498242
Cell. 2009 Dec 24;139(7):1315-26
pubmed: 20064377
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Cell. 2018 Jan 11;172(1-2):205-217.e12
pubmed: 29307488
PLoS One. 2013 Jun 26;8(6):e67316
pubmed: 23840661
Cancer Cell. 2020 Apr 13;37(4):471-484
pubmed: 32289271
Cancer Res. 2003 Nov 15;63(22):7785-90
pubmed: 14633704
Mol Ther. 2008 Apr;16(4):698-706
pubmed: 18362927
Cell. 2018 May 3;173(4):879-893.e13
pubmed: 29681456
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
Cancer. 1960 Jan-Feb;13:111-7
pubmed: 14423852
Genome Res. 2017 May;27(5):849-864
pubmed: 28396521
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Nat Cell Biol. 2020 Mar;22(3):310-320
pubmed: 32144411
Nat Commun. 2019 Feb 15;10(1):766
pubmed: 30770823
Nat Rev Clin Oncol. 2018 Feb;15(2):81-94
pubmed: 29115304
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Nat Methods. 2012 Feb 28;9(3):245-53
pubmed: 22373911
Commun Biol. 2019 Aug 9;2:306
pubmed: 31428694
Comput Intell Neurosci. 2016;2016:4037380
pubmed: 27212939
Cold Spring Harb Symp Quant Biol. 2005;70:149-58
pubmed: 16869748
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nature. 2015 Apr 16;520(7547):358-62
pubmed: 25855289
Nat Commun. 2018 May 23;9(1):2028
pubmed: 29795293
Oncogene. 2021 Jan;40(1):12-27
pubmed: 33046799
Front Immunol. 2019 Jul 31;10:1818
pubmed: 31417576
Nature. 2014 Aug 14;512(7513):155-60
pubmed: 25079324
J Vis Exp. 2014 Aug 06;(90):e51669
pubmed: 25145579
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
J Clin Invest. 2018 Apr 2;128(4):1371-1383
pubmed: 29480819
Nat Med. 2011 Apr;17(4):504-9
pubmed: 21441917
J Exp Med. 1991 Dec 1;174(6):1483-9
pubmed: 1660525
J Clin Oncol. 2012 Feb 10;30(5):525-32
pubmed: 22253462
Cell Metab. 2015 Oct 6;22(4):577-89
pubmed: 26365179
Nat Rev Cancer. 2015 Aug;15(8):473-83
pubmed: 26156638
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):E854-63
pubmed: 26831077
Curr Med Res Opin. 2015 Mar;31(3):557-74
pubmed: 25651481
Nat Cell Biol. 2019 Jul;21(7):879-888
pubmed: 31263265
Nature. 2018 Aug;560(7718):325-330
pubmed: 30089904
J Clin Invest. 2005 Jan;115(1):44-55
pubmed: 15630443
Cancer Cell. 2007 Nov;12(5):445-56
pubmed: 17996648
Nature. 2013 Sep 19;501(7467):365-72
pubmed: 24048069
Nat Rev Cancer. 2012 Apr 19;12(5):323-34
pubmed: 22513401
Signal Transduct Target Ther. 2017;2:
pubmed: 29158945